Global biosimilar regulatory harmonization will be needed to reduce development costs and improve patient access, despite ...

The UK health service has well over a decade’s experience of dealing with biosimilars, but the NHS acknowledges that it has yet to make the most of these drugs. That was certainly one of the ...

Novartis' Sandoz division has filed its biosimilar of Humira in the US, aiming to take a share of its multi-billion dollar revenues once its patent expires. The generics and biosimilars arm of ...

Share prices of Broadcom (NASDAQ: AVGO) initially soared on March 6 after the chipmaker saw robust artificial intelligence ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

“The man's family, who was there, agreed to the procedure, and they also said that I could stay and photograph as EMTs worked to save his life,” said John Moore, a Getty Images photographe ...

The denosumab biosimilar market is poised for disruption with 3 FDA-approved biosimilars, at least 5 awaiting approval, and ...

When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. I’ve been testing and reviewing the best TVs for nearly 30 years and have witnessed ...

Although advanced biologics offer hope, their high prices add to the distress. Fortunately, now more affordable biosimilars- nearly identical to biologics – can substantially reduce costs. Therapeutic ...

After hours: March 14 at 7:59:08 PM EDT Loading Chart for HD ...

SAN FRANCISCO — New data suggest that lenacapavir delivered just once per year could be as effective for HIV prevention as the twice-yearly injections already under review by the FDA.